Colorectal%20cancer Signs and Symptoms

Signs and Symptoms

Definition

Carcinoma arising from the epithelial lining of the colon or of the rectum
Incidence is higher in males
Most colorectal cancers arise from adenomatous polyps
Strongly linked to age, with 83% occurring in people ≥60 years old
Rectal cancer is defined as cancerous lesions located within 12 cm of the anal verge (with rigid proctoscopy)

Signs and Symptoms

Right-sided colonic lesions may present as:
- Vague abdominal pain
- Weight loss
- Anemia secondary to chronic blood loss
- Weakness
- Abdominal mass

Left-sided colonic lesions may present as:
- Colicky abdominal pain
- Changes in bowel habits (constipation alternating with diarrhea) or narrowing of stools
- Obstructive symptoms like nausea and vomiting

Lesions in the rectum may present as:
- Changes in bowel habits
- New onset or recurrent or persistent rectal bleeding
- Rectal urgency or fullness
- Tenesmus

Risk Factors

Age: Chances are increased markedly after the age of 50
Race: Colorectal cancer incidence and mortality rates are highest among African-Americans
Personal history of colorectal cancer: Chances of developing new cancers in other parts of the colon or rectum is still possible even after removal of previous colorectal cancer; risk is increased in those who had their first colorectal cancer at a young age
Personal history of colorectal polyps: Adenomatous polyps, especially multiple, large ones (>2 cm has a reported 40% chance of malignant transformation), increase the risk of developing colorectal cancer
Malignant transformation is higher for villous and tubulovillous adenomas
Familial adenomatous polyposis: Approximately 95% of FAP patients will develop adenomas by age 35 and if left untreated, has 100% chance of developing colorectal cancer
Hereditary nonpolyposis colorectal cancer or hereditary nonpolyposis colorectal cancer (Lynch syndrome): Transmitted as an autosomal dominant trait
- Amsterdam II criteria identify high-risk families suspected of having hereditary nonpolyposis colorectal:
  - Colorectal cancer affecting ≥2 generations
  - ≥3 relatives with a histologically diagnosed hereditary nonpolyposis colorectal-associated cancer (eg colorectal cancer, small bowel, endometrial, renal pelvis or ureteral cancer)
  - ≥1 colorectal cancers diagnosed at <50 years of age
- In suspected Lynch syndrome without a known familial mutation, first step in genetic diagnosis is identifying microsatellite instability in tumor cells

Personal history of inflammatory bowel disease (ulcerative colitis, Crohn’s disease): Increases risk for colorectal cancer; colorectal screening should be done more frequently
- Risk of colorectal cancer in a patient with ulcerative colitis depends on extent of colitis, duration of active disease and symptoms, development of mucosal dysplasia
- Risk of colorectal cancer in Crohn’s disease is also increased but to a lesser extent
- In patients with ulcerative colitis, overall incidence of colorectal cancer is 3.7%, with 2% probability by 10 years, and 8% by 20 years
- In patients with Crohn’s colitis, risk for colorectal cancer is similar while it appears that there is no significant risk associated with proctitis

Family history of colorectal cancer: Risk is highest in those with >1 affected first-degree relative (parent, siblings) or in those whose first-degree relative had colorectal cancer at a young age
Type 2 diabetes mellitus: Increases the risk of colorectal cancer and tends to have a less favorable prognosis
Diet: Consumption of red and processed meats, fat and cholesterol-rich diets have been linked to an increased risk of colorectal cancer
Heavy alcohol consumption: Increased risk of colorectal cancer is probably due to low levels of folic acid among heavy drinkers
Obesity
- Both overweight and obese people are at increased risk of colorectal cancer
- Pattern of fat distribution relates to the colorectal cancer risk (abdominal obesity being a stronger risk factor than truncal obesity or BMI)
- Obesity approximately increases by 2x the risk of adenomas (particularly, ≥1 cm, tubulovillous adenomas)

Smoking: Studies of recent years have found association between smoking and colorectal cancer, with relative risks between 1.5-3
Sedentary lifestyle

Tumour-treating fields – a versatile treatment modality for multiple cancer types

Dr. Uri Weinberg, Dr. David Tran, Prof. Thomas Seufferlein, 13 Dec 2021

Tumour-treating fields (TTFields) are a noninvasive cancer treatment modality, which first demonstrated clinical benefits in combination with chemotherapy in glioblastoma multiforme (GBM). At a webinar organized by the Hong Kong Cancer Therapy Society (HKCTS), experts discussed TTFields’ potential in other cancer types, including hepatocellular carcinoma (HCC) and pancreatic cancer, and the rationale for combining TTFields with immunotherapy.

Adding an androgen-receptor inhibitor to docetaxel and ADT in patients with mHSPC

Dr. Adrian Tse, 13 Dec 2023

A 68-year-old male patient presented with bone pain at multiple sites in November 2022. He did not have any other symptoms. He had hypertension and type 2 diabetes mellitus (T2DM), which were well controlled with amlodipine besylate 5 mg BID and metformin 1 g BID, respectively. He was generally well and had a baseline Eastern Cooperative Oncology Group (ECOG) performance status (PS) of 0.

Use of a novel erythroid maturation agent in transfusion-dependent β-thalassaemia

Dr. Gloria Yu-Yan Hwang, 28 Apr 2023

A 45-year-old female, diagnosed in infancy with transfusion-dependent β-thalassaemia (TDT) major of β⁰/β⁰genotype, presented with a liver abscess in December 2019. She was admitted to hospital multiple times for repeated drainage of the abscess, which was caused by Klebsiella, and required several prolonged courses of antibiotic treatment. The patient was on a regular transfusion schedule of 3 red blood cell (RBC) units every 4 weeks in addition to iron chelator therapy with intravenous (IV) deferoxamine and oral deferasirox.